DCK anticorps (AA 17-260)

N° du produit ABIN7871215

Cet anticorps anti-DCK Monoclonal Souris (Clone 3G10) (ABIN7871215) détecte spécifiquement DCK dans WB, IF, IHC (p) et FACS. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour DCK anticorps (AA 17-260) (ABIN7871215)

Antigène: DCK (Deoxycytidine Kinase (DCK))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp DCK est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Clone: 3G10

Détail du produit anti-DCK anticorps

Épitope: AA 17-260

Fonction: DCK Antibody

Purification: Affinity purified

Immunogène: A human recombinant protein (amino acids E17-L260) was used as the immunogen for the DCK antibody.

Isotype: IgG2b

Information d'application

Indications d'application: Optimal dilution of the DCK antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

Stock: 4 °C,-20 °C

Stockage commentaire: After reconstitution, the DCK antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Détails sur DCK

Antigène: DCK (Deoxycytidine Kinase (DCK))

Autre désignation: DCK

Sujet: Deoxycytidine kinase (dCK) is an enzyme which is encoded by the DCK gene in humans. Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity.

UniProt: P27707